comparemela.com
Home
Live Updates
Legend Capitals Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China - Press Release : comparemela.com
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China - Press Release
HONG KONG, Apr 24, 2022 - (ACN Newswire) - Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital's co-founded company Innostellar
Related Keywords
China
,
Fenghua
,
Zhejiang
,
Chinese
,
Innovent Biologics
,
Exegenesis Bio
,
Innostellar Biotherapeutics
,
Recbio Technology
,
Kawin Technology
,
Lynk Pharmaceuticals
,
National Medical Products Administration Of China
,
National Clinical Research Center
,
Shanghai Langsheng Biotechnology Co Ltd
,
Legend Capital
,
Drug Evaluation
,
National Medical Products Administration
,
Eye Diseases
,
Harbour Biomed
,
Suzhou Ribo Life Science
,
comparemela.com © 2020. All Rights Reserved.